Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (1)
- (-) Cybersecurity (2)
- (-) Fusion (1)
- (-) Neutron Science (1)
- (-) Security (2)
- Advanced Reactors (4)
- Artificial Intelligence (5)
- Big Data (4)
- Computer Science (11)
- Environment (1)
- Grid (1)
- Isotopes (2)
- Machine Learning (5)
- Materials Science (1)
- Molten Salt (3)
- Nuclear Energy (14)
- Quantum Science (1)
- Space Exploration (2)
- Transportation (1)
Media Contacts
As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.
Oak Ridge National Laboratory will give college students the chance to practice cybersecurity skills in a real-world setting as a host of the Department of Energy’s fifth collegiate CyberForce Competition on Nov. 16. The event brings together student teams from across the country to compete at 10 of DOE’s national laboratories.
Three researchers at Oak Ridge National Laboratory will lead or participate in collaborative research projects aimed at harnessing the power of quantum mechanics to advance a range of technologies including computing, fiber optics and network
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
Thought leaders from across the maritime community came together at Oak Ridge National Laboratory to explore the emerging new energy landscape for the maritime transportation system during the Ninth Annual Maritime Risk Symposium.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.